[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3881801D1 - Menschliche somatomedin-traeger-protein-untereinheiten und verfahren zu ihrer herstellung. - Google Patents

Menschliche somatomedin-traeger-protein-untereinheiten und verfahren zu ihrer herstellung.

Info

Publication number
DE3881801D1
DE3881801D1 DE8888904042T DE3881801T DE3881801D1 DE 3881801 D1 DE3881801 D1 DE 3881801D1 DE 8888904042 T DE8888904042 T DE 8888904042T DE 3881801 T DE3881801 T DE 3881801T DE 3881801 D1 DE3881801 D1 DE 3881801D1
Authority
DE
Germany
Prior art keywords
carrier
units
production
human
somatomedin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888904042T
Other languages
English (en)
Other versions
DE3881801T2 (de
Inventor
Emerald Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celtrix Pharmaceuticals Inc
Original Assignee
Celtrix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celtrix Pharmaceuticals Inc filed Critical Celtrix Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3881801D1 publication Critical patent/DE3881801D1/de
Publication of DE3881801T2 publication Critical patent/DE3881801T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE88904042T 1987-04-06 1988-03-31 Menschliche somatomedin-träger-protein-untereinheiten und verfahren zu ihrer herstellung. Expired - Fee Related DE3881801T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3488587A 1987-04-06 1987-04-06

Publications (2)

Publication Number Publication Date
DE3881801D1 true DE3881801D1 (de) 1993-07-22
DE3881801T2 DE3881801T2 (de) 1993-12-23

Family

ID=21879212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88904042T Expired - Fee Related DE3881801T2 (de) 1987-04-06 1988-03-31 Menschliche somatomedin-träger-protein-untereinheiten und verfahren zu ihrer herstellung.

Country Status (11)

Country Link
EP (2) EP0308500B1 (de)
JP (1) JP2648951B2 (de)
AT (1) ATE90690T1 (de)
AU (1) AU627423B2 (de)
CA (1) CA1340295C (de)
DE (1) DE3881801T2 (de)
DK (1) DK677688D0 (de)
ES (1) ES2058341T3 (de)
IL (1) IL85983A (de)
WO (1) WO1988007863A1 (de)
ZA (1) ZA882407B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
EP0418230B1 (de) * 1988-04-12 1995-12-27 Amgen Boulder Inc. Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors
ATE125268T1 (de) * 1988-07-15 1995-08-15 Cent Sydney Area Health Serv Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
EP0800530A4 (de) * 1994-07-20 1998-12-02 Celtrix Pharma Igf/igfbp-komplex zur förderung der knochenentwicklung und zur regulation des knochenumbaus
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
AU762351B2 (en) 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
IL143834A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
ES2301547T3 (es) 2000-05-16 2008-07-01 Genentech, Inc. Tratamiento de trastornos del cartilago.
AU2002248609B2 (en) 2001-03-14 2007-03-01 Genentech, Inc. IGF antagonist peptides
ES2527871T3 (es) 2003-05-01 2015-02-02 Imclone Llc Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana
NZ545940A (en) 2003-09-12 2009-12-24 Tercica Inc Methods for treatment of insulin-like growth factor-1 (IGF-1) deficiency
EP1670822A2 (de) 2003-10-03 2006-06-21 Genentech, Inc. Igf-bindende proteine
DK2100614T3 (da) 2005-06-17 2013-10-28 Imclone Llc Antistof mod PDGFR-alfa til anvendelse ved behandlingen af tumorer
WO2007092453A2 (en) 2006-02-03 2007-08-16 Imclone Systems Incorporated Igf-ir antagonists as adjuvants for treatment of prostate cancer
PE20201166A1 (es) 2017-09-11 2020-10-28 Shire Human Genetic Therapies Metodos y composiciones para tratar enfermedades pulmonares cronicas
KR20230113287A (ko) 2020-10-19 2023-07-28 오크 힐 바이오 리미티드 신생아에 사용하기에 적합한 조성물
MX2024008819A (es) 2022-01-19 2024-09-17 Oak Hill Bio Ltd Composiciones y metodos para reducir la oxidacion de igf-1/igfbp.
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2024170612A1 (en) 2023-02-14 2024-08-22 Oak Hill Bio Limited Treatment of healing dysregulation in gi tissue

Also Published As

Publication number Publication date
IL85983A0 (en) 1988-09-30
ZA882407B (en) 1988-09-28
JP2648951B2 (ja) 1997-09-03
AU1702088A (en) 1988-11-04
CA1340295C (en) 1998-12-29
EP0308500A1 (de) 1989-03-29
IL85983A (en) 1994-10-07
ATE90690T1 (de) 1993-07-15
DE3881801T2 (de) 1993-12-23
AU627423B2 (en) 1992-08-27
ES2058341T3 (es) 1994-11-01
EP0308500B1 (de) 1993-06-16
JPH01502986A (ja) 1989-10-12
DK677688A (da) 1988-12-05
WO1988007863A1 (en) 1988-10-20
DK677688D0 (da) 1988-12-05
EP0294021A1 (de) 1988-12-07

Similar Documents

Publication Publication Date Title
DE3881801D1 (de) Menschliche somatomedin-traeger-protein-untereinheiten und verfahren zu ihrer herstellung.
EP0451194A4 (en) Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
PT92278A (pt) Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina
DE68929510D1 (de) Nukleotidsequenzen, die für ein Protein mit Ureaseaktivität kodieren
DE3882055D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarboxylsaeure-verbindungen.
DE69000125D1 (de) Verfahren zum verbinden von elementen zur herstellung von teilen aus mehrstrukturellem verbundmaterial.
FI895935A0 (fi) Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi
DE69319012D1 (de) Protein mit Knochenbildungs-Eigenschaften und Verfahren zu seiner Herstellung
ATE186781T1 (de) Verfahren zur herstellung von testelementen
AT381629B (de) Verfahren zur herstellung von eiweissreichen schokoladenprodukten
FI101542B1 (fi) Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi
DE69523605D1 (de) Verfahren zur herstellung vom aktieven protein dimerischen
AU576508B2 (en) Sythetic peptides antigenically corresponding to brain specific proteinoids
ATE127478T1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
DE3482021D1 (de) Verfahren zur erhoehung der milchleistung von milchliefernden kuehen mittels futter, verfahren zur herstellung dieses futters und apparat zur durchfuehrung dieses verfahrens.
ATE81013T1 (de) Verfahren zur herstellung von faktor viii:cmangelplasma und ein so erhaltenes mangelplasma.
ATE190653T1 (de) Verfahren zur herstellung von rekombinanten und synthetischen peptiden und deren verwendung
DE3853092D1 (de) Verfahren zur Herstellung von Proteinen, die nicht in Proteinen vorkommende Aminosäuren enthalten.
DE3881101D1 (de) Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper.
DE68923232D1 (de) Verfahren zur herstellung von pyridin-2,3-dicarbonsäure-verbindungen.
DE3771799D1 (de) Verfahren zur herstellung von heterozyklen durch palladium-zyklische komplexe.
ATE27159T1 (de) Carbapenamverbindung und verfahren zu ihrer herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee